Interferon-γ- and glucocorticoid-mediated pathways synergize to enhance death of CD4+ CD8+ thymocytes during Salmonella enterica serovar Typhimurium infection

Immunology

Volumn 138, Issue 4, 2013, Pages 307-321

  Deobagkar Lele, Mukta ^a   Chacko, Suni K ^a   Victor, Emmanuel S ^a   Kadthur, Jayachandra C ^a   Nandi, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Atrophy; Cytokines; Glucocorticoids; Interferon ; Thymus

Indexed keywords

CASPASE 3; GAMMA INTERFERON; GLUCOCORTICOID; HYDROCORTISONE; MIFEPRISTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNE RESPONSE; MITOCHONDRION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEROTYPE; SURVIVAL; THYMOCYTE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CASPASE 3; CELL COUNT; CELL DEATH; GENE EXPRESSION REGULATION; HORMONE ANTAGONISTS; HYDROCORTISONE; INTERFERON-GAMMA; MICE; MICE, KNOCKOUT; MIFEPRISTONE; RECEPTORS, GLUCOCORTICOID; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; STEM CELLS; SURVIVAL RATE; THYMOCYTES; THYMUS GLAND;

EID: 84874959578     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12047     Document Type: Article

References (58)

1. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol 2009; 30:366-73.
2. Brady HJ, Salomans GS, Bobedijk RC, Berns AJM. T cells from bax-α transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage induced cell death in the absence of p53 gene product. EMBO J 1996; 15:1221-30.
3. Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, Patel DD, Haynes BF. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and are associated with thymic atrophy. J Immunol 2000; 164:2180-7.
4. Sutherland JS, Goldberg GL, Hammett MV et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 2005; 175:2741-53.
5. Wang X, Hsu HC, Wang Y, Edwards CK III, Yang P, Wu Q, Mountz JD. Phenotype of genetically regulated thymic involution in young BXD RI strains of mice. Scand J Immunol 2006; 64:287-94.
6. Dooley J, Liston A. Molecular control over thymic involution: from cytokines and microRNA to aging and adipose tissue. Eur J Immunol 2012; 42:1073-9.
7. Youm YH, Kanneganti TD, Vandanmagsar B et al. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Rep 2012; 1:56-68.
8. Savino W. The thymus is a common target organ in infectious diseases. PLoS Pathog 2006; 2:e62.
9. Scofield VL, Yan M, Kuang X, Kim SJ, Wong PK. The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus. Immunol Lett 2009; 122:150-8.
10. Mandel TE, Cheers C. Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains. Infect Immun 1980; 30:851-61.
11. Ito M, Nishiyama K, Hyodo S, Shigeta S, Ito T. Weight reduction of thymus and depletion of lymphocytes of T-dependent areas in peripheral lymphoid tissues of mice infected with Francisella tularensis. Infect Immun 1985; 49:812-18.
12. Zhang YH, Takahashi K, Jiang GZ, Kawai M, Fukada M, Yokochi T. In vivo induction of apoptosis (programmed cell death) in mouse thymus by administration of lipopolysaccharide. Infect Immun 1993; 61:5044-8.
13. + thymocyte depletion. Microb Pathog 2005; 39:189-96.
14. Chung CS, Chen Y, Grutkoski PS, Doughty L, Ayala A. SOCS-1 is a central mediator of steroid-increased thymocyte apoptosis and decreased survival following sepsis. Apoptosis 2007; 12:1143-53.
15. Roggero E, Pérez AR, Tamae-Kakazu M, Piazzon I, Nepomnaschy I, Besedovsky HO, Bottasso OA, del Rey A. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol 2006; 190:495-503.
16. Pérez AR, Roggero E, Nicora A, Palazzi J, Besedovsky HO, Del Rey A, Botasso OA. Thymus atrophy during Trypanosoma cruzi infection is caused by an immuno-endocrine imbalance. Brain Behav Immun 2007; 21:890-900.
17. Gougeon ML. Programmed cell death in HIV infection: dysregulation of BCL-2 and Fas pathways and contribution to AIDS pathogenesis. Psychoneuroendocrinology 1997; 22:S33-9.
18. Rosenzweig M, Connole M, Forand-Barabasz A, Tremblay MP, Johnson RP, Lackner AA. Mechanisms associated with thymocyte apoptosis induced by simian immunodeficiency virus. J Immunol 2000; 165:3461-8.
19. Fayad R, Sennello JA, Kim SH, Pini M, Dinarello CA, Fantuzzi G. Induction of thymocyte apoptosis by systemic administration of concanavalin A in mice: role of TNFα, IFNγ and glucocorticoids. Eur J Immunol 2005; 35:2304-12.
20. + double-positive thymocytes in mice infected with Trypanosoma cruzi. Microbes Infect 2003; 5:1363-71.
21. Kato Y, Morikawa A, Sugiyama T, Koide N, Jiang GZ, Lwin T, Yoshida T, Yokochi T. Augmentation of lipopolysaccharide-induced thymocyte apoptosis by interferon-γ. Cell Immunol 1997; 177:103-8.
22. Sempowski GD, Rhein ME, Scearce RM, Haynes BF. Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy. Eur J Immunol 2002; 32:3066-70.
23. Wang SD, Huang KJ, Lin YS, Lei HY. Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 1994; 152:5014-21.
24. Billard MJ, Gruver AL, Sempowski GD. Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS ONE 2011; 6:e17940.
25. Nobrega C, Cardona PJ, Roque S, Pinto do O P, Appelberg R, Correia-Neves M. The thymus as a target for mycobacterial infections. Microbes Infect 2007; 9:1521-9.
26. Nobrega C, Roque S, Nunes-Alves C, Coelho A, Medeiros I, Castro AG, Appelberg R, Correia-Neves M. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J Immunol 2010; 184:351-8.
27. Patil V, Kumar A, Kuruppath S, Nandi D. Peptidase N encoded by Salmonella enterica serovar Typhimurium modulates systemic infection in mice. FEMS Immunol Med Microbiol 2007; 51:431-42.
28. Jones BD. Host responses to pathogenic Salmonella infection. Genes Dev 1997; 11:679-87.
29. Dougan G, John V, Palmer S, Mastroeni P. Immunity to salmonellosis. Immunol Rev 2011; 240:196-210.
30. -/- mice. Immunobiology 2012; 217:354-62.
31. m) in apoptosis; an update. Apoptosis 2003; 8:115-28.
32. Macho A, Decaudin D, Castedo M, Hirsch T, Susin SA, Zamzami N, Kroemer G. Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry 1996; 25:333-40.
33. Herold MJ, McPherson KG, Reichardt HM. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006; 63:60-72.
34. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 2003; 178:2249-54.
35. Godfraind C, Holmes KV, Coutelier JP. Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice. J Virol 1995; 69:6541-7.
36. Dion ML, Poulin JF, Bordi R et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004; 21:757-68.
37. Ho Tsong Fang R, Colantonio AD, Uittenbogaart CH. The role of the thymus in HIV infection: a 10 year perspective. AIDS 2008; 22:171-84.
38. van den Brink MR, Alpdogan O, Boyd RL. Strategies to enhance T-cell reconstitution in immuno-compromised patients. Nat Rev Immunol 2004; 4:856-67.
39. Lee JC, Boechat MI, Belzer M et al. Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy. AIDS 2006; 20:667-74.
40. Westrop SJ, Qazi NA, Pido-Lopez J, Nelson MR, Gazzard B, Gotch FM, Imami N. Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers. PLoS ONE 2009; 4:e5474.
41. Li T, Wu N, Dai Y, Qiu Z, Han Y, Xie J, Zhu T, Li Y. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis 2011; 53:944-51.
42. Garrido C, Rallón N, Soriano V, Lopez M, Zahonero N, de Mendoza C, Benito JM. Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir. AIDS 2012; 26:551-7.
43. Cotta-de-Almeida V, Bonomo A, Mendes-da-Cruz DA et al. Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration. Eur J Immunol 2003; 33:2439-48.
44. Verinaud L, Da Cruz-Höfling MA, Sakurada JK, Rangel HA, Vassallo J, Wakelin D, Sewell HF, Camargo IJ. Immunodepression induced by Trypanosoma cruzi and mouse hepatitis virus type 3 is associated with thymus apoptosis. Clin Diagn Lab Immunol 1998; 5:186-91.
45. + double-positive thymocytes. Antimicrob Agents Chemother 2005; 49:1981-7.
46. Koka PS, Brooks DG, Razai A, Kitchen CM, Zack JA. HIV type 1 infection alters cytokine mRNA expression in thymus. AIDS Res Hum Retroviruses 2003; 19:1-12.
47. Andrade CF, Gameiro J, Nagib PR, Carvalho BO, Talaisys RL, Costa FT, Verinaud L. Thymic alterations in Plasmodium berghei-infected mice. Cell Immunol 2008; 253:1-4.
48. + thymocytes in experimentally infected mice. Immunobiology 2011; 216:1148-54.
49. Yajima N, Sakamaki K, Yonehara S. Age-related thymic involution is mediated by Fas on thymic epithelial cells. Int Immunol 2004; 16:1027-35.
50. Henriques-Pons A, De Meis J, Cotta-de-Almeida V, Savino W, Araújo-Jorge TC. Fas and perforin are not required for thymus atrophy induced by Trypanosoma cruzi infection. Exp Parasitol 2004; 107:1-4.
51. Fiala C, Gemzel-Danielsson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 2006; 74:66-86.
52. Baulieu EE. RU486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996. Ann N Y Acad Sci 1997; 828:47-58.
53. Cadepond F, Ulmann A, Baulieu EE. RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 1997; 48:129-56.
54. Muotiala A, Mäkela PH. The role of IFN-γ in murine Salmonella typhimurium infection. Microb Pathog 1990; 8:135-41.
55. Nauciel C, Espinasse-Maes F. Role of γ interferon and tumor necrosis factor α in resistance to Salmonella typhimurium infection. Infect Immun 1992; 60:450-4.
56. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Role of T cells, TNFα and IFNγ in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro-Salmonella vaccines. Microb Pathog 1992; 13:477-91.
57. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for γ interferon. Infect Immun 1994; 62:2590-9.
58. de Meis J, Morrot A, Farias-De-Oliveira DA, Villa-Verde DM, Savino W. Differential regional immune response in Chagas disease. PLoS Negl Trop Dis 2009; 3:e417.